Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 38 | 31 | 29 | 29 | 26 |
| Gross Profit | 38 | 31 | 29 | 29 | 26 |
| Operating Expenses | 1,857 | 2,160 | 2,357 | 2,207 | 1,215 |
| Operating Income | -1,819 | -2,129 | -2,328 | -2,178 | -1,189 |
| Interest Expense | 395 | 328 | 317 | 283 | 257 |
| Other Income | -2,843 | -1,700 | -1,238 | -1,109 | -1,479 |
| Pre-tax Income | -5,057 | -4,157 | -3,883 | -3,571 | -2,925 |
| Net Income Continuous | -5,057 | -4,157 | -3,883 | -3,571 | -2,925 |
| Net Income | $-5,057 | $-4,157 | $-3,883 | $-3,571 | $-2,925 |
| EPS Basic Total Ops | -766.67 | -800.00 | -933.33 | -1,100.00 | -1,300.00 |
| EPS Basic Continuous Ops | -783.30 | -791.44 | -948.55 | -1,063.89 | -1,315.85 |
| EPS Diluted Total Ops | -766.67 | -800.00 | -933.33 | -1,100.00 | -1,300.00 |
| EPS Diluted Continuous Ops | -783.30 | -791.44 | -948.55 | -1,063.89 | -1,315.85 |
| EBITDA(a) | $-276 | $-1,085 | $-1,533 | $-1,715 | $-587 |